Q BioMed Inc. is a biotech acceleration and commercialization company based in New York, NY. They specialize in acquiring, developing, and financing undervalued biomedical assets in various therapeutic areas, with a focus on the biotechnology and healthcare sectors. Their strategic approach involves minimizing risk, sharing success, and accelerating technologies from incubation to monetization, ultimately aiming to provide public market access for private company assets.
With expertise in business product development and capital formation, Q BioMed Inc. aims to bridge the gap for biomedical start-ups lacking capital and resources to transition from incubation to development and beyond. Their strategy revolves around maximizing risk-adjusted returns by focusing on value-driven assets, ranging from early-stage to near-revenue businesses, where technical, regulatory, and commercial risks have been mitigated or where major valuation inflections are imminent.
Generated from the website